Home › Therapeutic areas › Metabolic › Congenital Hyperinsulinism
Congenital Hyperinsulinism (1 companies)
Companies with an active program in Congenital Hyperinsulinism.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| AMLX | Amylyx Pharmaceuticals, Inc. | MetabolicNeurology Rare | 1 | Phase 3 | 5 |
No companies match.